146 related articles for article (PubMed ID: 15294002)
1. Fluorescent pirenzepine derivatives as potential bitopic ligands of the human M1 muscarinic receptor.
Tahtaoui C; Parrot I; Klotz P; Guillier F; Galzi JL; Hibert M; Ilien B
J Med Chem; 2004 Aug; 47(17):4300-15. PubMed ID: 15294002
[TBL] [Abstract][Full Text] [Related]
2. Exploration of the orthosteric/allosteric interface in human M1 muscarinic receptors by bitopic fluorescent ligands.
Daval SB; Kellenberger E; Bonnet D; Utard V; Galzi JL; Ilien B
Mol Pharmacol; 2013 Jul; 84(1):71-85. PubMed ID: 23604140
[TBL] [Abstract][Full Text] [Related]
3. On the use of nonfluorescent dye labeled ligands in FRET-based receptor binding studies.
Tahtaoui C; Guillier F; Klotz P; Galzi JL; Hibert M; Ilien B
J Med Chem; 2005 Dec; 48(24):7847-59. PubMed ID: 16302823
[TBL] [Abstract][Full Text] [Related]
4. Fluorescent derivatives of AC-42 to probe bitopic orthosteric/allosteric binding mechanisms on muscarinic M1 receptors.
Daval SB; Valant C; Bonnet D; Kellenberger E; Hibert M; Galzi JL; Ilien B
J Med Chem; 2012 Mar; 55(5):2125-43. PubMed ID: 22329602
[TBL] [Abstract][Full Text] [Related]
5. A fluorescence anisotropy assay for the muscarinic M1 G-protein-coupled receptor.
Huwiler KG; De Rosier T; Hanson B; Vogel KW
Assay Drug Dev Technol; 2010 Jun; 8(3):356-66. PubMed ID: 20233092
[TBL] [Abstract][Full Text] [Related]
6. Pirenzepine promotes the dimerization of muscarinic M1 receptors through a three-step binding process.
Ilien B; Glasser N; Clamme JP; Didier P; Piemont E; Chinnappan R; Daval SB; Galzi JL; Mely Y
J Biol Chem; 2009 Jul; 284(29):19533-43. PubMed ID: 19451648
[TBL] [Abstract][Full Text] [Related]
7. A rapid and versatile method to label receptor ligands using "click" chemistry: Validation with the muscarinic M1 antagonist pirenzepine.
Bonnet D; Ilien B; Galzi JL; Riché S; Antheaune C; Hibert M
Bioconjug Chem; 2006; 17(6):1618-23. PubMed ID: 17105244
[TBL] [Abstract][Full Text] [Related]
8. Fluorescence resonance energy transfer to probe human M1 muscarinic receptor structure and drug binding properties.
Ilien B; Franchet C; Bernard P; Morisset S; Weill CO; Bourguignon JJ; Hibert M; Galzi JL
J Neurochem; 2003 May; 85(3):768-78. PubMed ID: 12694403
[TBL] [Abstract][Full Text] [Related]
9. Fluorescent muscarinic EGFP-hM1 chimeric receptors: design, ligand binding and functional properties.
Weill C; Ilien B; Goeldner M; Galzi JL
J Recept Signal Transduct Res; 1999; 19(1-4):423-36. PubMed ID: 10071775
[TBL] [Abstract][Full Text] [Related]
10. Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.
Gharagozloo P; Lazareno S; Popham A; Birdsall NJ
J Med Chem; 1999 Feb; 42(3):438-45. PubMed ID: 9986715
[TBL] [Abstract][Full Text] [Related]
11. FRET-based sensors for the human M1-, M3-, and M5-acetylcholine receptors.
Ziegler N; Bätz J; Zabel U; Lohse MJ; Hoffmann C
Bioorg Med Chem; 2011 Feb; 19(3):1048-54. PubMed ID: 20716489
[TBL] [Abstract][Full Text] [Related]
12. Identification of various allosteric interaction sites on M1 muscarinic receptor using 125I-Met35-oxidized muscarinic toxin 7.
Fruchart-Gaillard C; Mourier G; Marquer C; Ménez A; Servent D
Mol Pharmacol; 2006 May; 69(5):1641-51. PubMed ID: 16439611
[TBL] [Abstract][Full Text] [Related]
13. Development of a new type of allosteric modulator of muscarinic receptors: hybrids of the antagonist AF-DX 384 and the hexamethonio derivative W84.
Mohr M; Heller E; Ataie A; Mohr K; Holzgrabe U
J Med Chem; 2004 Jun; 47(12):3324-7. PubMed ID: 15163212
[TBL] [Abstract][Full Text] [Related]
14. Long-term changes in the muscarinic M1 receptor induced by instantaneous formation of wash-resistant xanomeline-receptor complex.
De Lorme KC; Grant MK; Noetzel MJ; Polson SB; El-Fakahany EE
J Pharmacol Exp Ther; 2007 Dec; 323(3):868-76. PubMed ID: 17855477
[TBL] [Abstract][Full Text] [Related]
15. Position-specific incorporation of fluorescent non-natural amino acids into maltose-binding protein for detection of ligand binding by FRET and fluorescence quenching.
Iijima I; Hohsaka T
Chembiochem; 2009 Apr; 10(6):999-1006. PubMed ID: 19301314
[TBL] [Abstract][Full Text] [Related]
16. The effects of mercury on muscarinic cholinergic receptor subtypes (M1 and M2) in captive mink.
Basu N; Scheuhammer AM; Rouvinen-Watt K; Evans RD; Grochowina N; Chan LH
Neurotoxicology; 2008 Mar; 29(2):328-34. PubMed ID: 18295336
[TBL] [Abstract][Full Text] [Related]
17. New fluorescent adenosine A1-receptor agonists that allow quantification of ligand-receptor interactions in microdomains of single living cells.
Middleton RJ; Briddon SJ; Cordeaux Y; Yates AS; Dale CL; George MW; Baker JG; Hill SJ; Kellam B
J Med Chem; 2007 Feb; 50(4):782-93. PubMed ID: 17249651
[TBL] [Abstract][Full Text] [Related]
18. Functional characterization and potential applications for enhanced green fluorescent protein- and epitope-fused human M1 muscarinic receptors.
Weill C; Galzi JL; Chasserot-Golaz S; Goeldner M; Ilien B
J Neurochem; 1999 Aug; 73(2):791-801. PubMed ID: 10428077
[TBL] [Abstract][Full Text] [Related]
19. Investigation of the mechanism for the relaxation of rat duodenum mediated via M1 muscarinic receptors.
Hamrouni AM; Gudka N; Broadley KJ
Auton Autacoid Pharmacol; 2006 Jul; 26(3):275-84. PubMed ID: 16879493
[TBL] [Abstract][Full Text] [Related]
20. Fluorescent agonists for the Torpedo nicotinic acetylcholine receptor.
Krieger F; Mourot A; Araoz R; Kotzyba-Hibert F; Molgó J; Bamberg E; Goeldner M
Chembiochem; 2008 May; 9(7):1146-53. PubMed ID: 18386276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
